Rapid high-pressure liquid chromatographic determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N10-methylpteroic acid in biological fluids
- 1 March 1982
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 121 (1) , 103-113
- https://doi.org/10.1016/0003-2697(82)90562-0
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapyCancer Letters, 1980
- Antineoplastic AgentsTherapeutic Drug Monitoring, 1980
- High‐dose Methotrexate Therapy—An Area of Uncertainty*Australian and New Zealand Journal of Medicine, 1979
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.Journal of Clinical Investigation, 1976
- PURITY OF METHOTREXATEThe Lancet, 1975
- Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric methodBiochemical Medicine, 1974
- Synthesis and biologic evaluation of 7-hydroxymethotrexate, 7-methylaminopterin, and 7-methylmethotrexateJournal of Medicinal Chemistry, 1972
- Metabolite of 4-Amino-4-deoxy-N10-methylpteroylglutamic Acid (Methotrexate)Journal of Pharmaceutical Sciences, 1967
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948